Low-fat diet may help some women beat breast cancer, study suggests

December 13, 2014 by Karen Kaplan, Los Angeles Times
Credit: Wikipedia.

Almost anyone would benefit by reducing the amount of fat in their diet. But the upside could be especially big for women with breast cancer.

New research presented Friday at the San Antonio Breast Cancer Symposium suggests that a low- diet may extend the lives of some women with the disease.

The preliminary findings are based on data from early-stage patients who volunteered for the Women's Intervention Nutrition Study. All of the women had surgical treatments and were continuing with various combinations of hormone therapy, chemotherapy and radiation, depending on the characteristics of their tumors.

Among the 2,437 study participants, 975 were randomly assigned to revamp their diets. The goal was to get only 15 percent of their calories from fat, and to help them in this mission they received eight individual counseling sessions over 16 weeks, followed by check-ins with dietitians once every three months. The other 1,462 women in the study served as controls.

Before the study began, women in both groups were getting an average of 29.6 percent of their calories from fat. Six years later, the women in the low-fat diet group had reduced that figure to 23 percent, while their counterparts in the control group crept up to 31.4 percent. (The women who cut back on fat also lost about 6 pounds, on average.)

The possible benefits of cutting back on fat were apparent after five years, the researchers reported. The mortality rate for women in the low-fat diet group was 6.6 percent - nearly 10 percent lower than the 7.3 percent mortality rate for women in the control group, researchers reported.

The longer the women were tracked, the more the gap grew. After a median of 8.1 years, the mortality rate for those eating less fat was 9.1 percent - 18 percent lower than the 11.1 percent mortality rate for those in the control group. And through 2013, the mortality rates for the two groups were 13.6 percent and 17 percent; that amounted to a 20 percent reduction for women eating less fat.

None of these differences were big enough to be considered statistically significant. But when the researchers focused only on women whose cancers lacked receptors for the hormone estrogen, the death rate for women on low-fat diets was 36 percent lower than for women on the regular diets. That gap was too big to be due to chance.

Then the researchers zeroed in on women whose cancers lacked receptors for both estrogen and progesterone. They found the mortality rate was 56 percent lower for women on the low-fat diet than for women in the control group.

The researchers didn't know whether the women's tumors were HER2-positive or HER2-negative. (HER2-positive cancers have a faulty HER2 gene that causes breast cells to grow out of control.) But the researchers said some of the women with ER-negative and PR-negative cancers were probably negative for HER2 as well. These "triple-negative" breast cancers are difficult to treat because they don't respond to drugs like tamoxifen or Herceptin. So a lifestyle intervention that might improve survival for with these cancers is especially welcome, the researchers said.

The study was conducted by from the Los Angeles Biomedical Research Institute at the Harbor-UCLA Medical Center and Beth Israel Deaconess Hospital in Boston. The work was funded by the National Cancer Institute and the American Institute of Cancer Research.

Explore further: Breast cancer treatments more effective now than in the past

Related Stories

Breast cancer treatments more effective now than in the past

November 27, 2014
(HealthDay)—Comparison of recurrence and outcome patterns shows that current treatments for breast cancer are more effective than previous therapies, according to research published online Nov. 24 in the Journal of Clinical ...

Male breast cancer is different

December 9, 2014
(HealthDay)—Men's breast cancer differs in some ways from women's, new research finds.

Impact of adding bevacizumab to presurgery chemo for triple-negative breast cancer varies with subtype

December 12, 2014
Among women with triple-negative breast cancer, the benefit of adding bevacizumab to standard presurgery chemotherapy was greater for those whose cancers were classified as basal-like by gene expression assay compared with ...

Male and female breast cancers are not identical

December 12, 2014
Results of the EORTC10085/TBCRC/BIG/NABCG International Male Breast Cancer Program conducted in both Europe and in the United States and presented at the 2014 San Antonio Breast Cancer Symposium found significant improvement ...

Combined therapy linked to lower chance of recurrence in women with small, HER2+ breast cancers

December 11, 2013
In a new study, women with relatively small, HER2-positive breast tumors who received a combination of lower-intensity chemotherapy and a targeted therapy following surgery or radiation therapy were very unlikely to have ...

Lactation linked to reduced estrogen receptor-negative, triple-negative breast cancer risk

September 16, 2014
Women who have had children (parous women) appear to have an increased risk of developing estrogen receptor-negative breast cancer, the subtype that carries a higher mortality rate and is more common in women of African ancestry. ...

Recommended for you

Week 34 of pregnancy reduces breast cancer risk: study

October 23, 2018
Women's bodies undergo a "striking" change during a specific week of pregnancy that can significantly reduce their risk of developing breast cancer later in life, scientists said Tuesday.

New kind of compound shows early promise against prostate cancer

October 23, 2018
A new type of molecule blocks the action of genes that drive the growth of therapy-resistant prostate cancer, a new study finds.

New combination treatment flips the switch on melanoma cells

October 23, 2018
Think of the protein BH3 like a finger that turns off a cancer cell survival switch. The problem is that most cancer cells have found ways to remove this "finger—commonly, by breaking the action of a gene called p53 that ...

Desperate & duped? GoFundMe means big bucks for dubious care

October 23, 2018
People seeking dubious, potentially harmful treatment for cancer and other ailments raised nearly $7 million over two years from crowdfunding sites, a study found.

Marker found for condition that causes numerous tumors

October 23, 2018
UT Southwestern researchers have made a major advance in uncovering the biology of how thousands of disfiguring skin tumors occur in patients troubled by a genetic disorder called neurofibromatosis type 1 (NF1). This scientific ...

Urban and rural rates of childhood cancer survival the same, study finds

October 23, 2018
Childhood and adolescent cancer survival in the United States does not vary by rural/urban residence at the time of diagnosis, finds a new study from the Brown School at Washington University in St. Louis.


Adjust slider to filter visible comments by rank

Display comments: newest first

1 / 5 (1) Dec 13, 2014
Carbs cause the inflammation that causes cancer. The fat link is old news

Real question is how Italians can ingest carbs without incident. Gut bacteria might make the difference in outcomes

"Low fat" is marketing scam by dairy industry to make two products into two, often bought from same customer. They sell the skimmed milk and the creme separately and double their money from the same input
5 / 5 (1) Dec 13, 2014
There are lots of papers claiming that the ketogenic diet fights cancer. The ketogenic diet is low carb, moderate protein and high fat, so that the body starts to use ketones for fuel instead of glucose. That is quite the opposite to this "low fat" diet alluded to in the article.
So now I am confused.
not rated yet Dec 15, 2014
I'm fairly certain a high fat diet is a BAD idea in general.

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.